Search For "active pharmaceutical ingredients apis"
Sigachi Industries aims to increase Revenue Potential by INR 250 cr Commen
Updated : 2 months ago IST
Hyderabad (Telangana) [India], January 23: Sigachi Industries Ltd. (NSE: SIGACHI; BSE: 543389), a leading Indian pharmaceutical company, today announced a significant milestone in its research and development pipeline with the successful advancement of a new Cystic Fibrosis (CF) Active Pharm
Read More
Anlon Healthcare Delivers Over 102% Profit Growth in H1 FY26 & 259% in Q2F
Updated : 4 months, 1 week ago IST
Rajkot (Gujarat) [India], November 13: Anlon Healthcare Limited, one of India's leading manufacturers of high-purity pharmaceutical intermediates and active pharmaceutical ingredients (APIs), announced its unaudited financial results for the second Q2 and H1 FY26.
Read More
Sigachi Industries Sets the Gold Standard in Microcrystalline Cellulose (M
Updated : 9 months, 2 weeks ago IST
Hyderabad (Telangana) [India], June 13: Sigachi Industries Ltd., India's largest producer of Microcrystalline Cellulose (MCC), continues to set new benchmarks in global pharmaceutical excipients while strategically expanding into Active Pharmaceutical Ingredients (APIs) and specialty chem
Read More
Remlife Global Partners With JiyaYu Lifesciences To Replace Animal Inputs
Updated : 10 months, 3 weeks ago IST
New Delhi [India], May 9: Remlife Global PTE LTD., a Singapore-based subsidiary of BSE-listed Remedium Lifecare Ltd. (India), is pleased to announce a forward-looking partnership with JiyaYu Lifesciences PTE Ltd., a green chemistry technology platform company. This collaboration is focused o
Read More
Celebrating the Legacy of Excellence and Innovation, Zydus Takeda Healthca
Updated : 1 year, 1 month ago IST
Mumbai, Vashi (Maharashtra) [India], January 31: Zydus Takeda Healthcare Private Limited (ZTHPL), a joint venture company set up by Zydus Lifesciences Limited and Takeda Pharmaceutical Company Limited (Takeda) (TSE:4502/NYSE:TAK), celebrates the 25th anniversary of the Vashi manufacturing pl
Read More
Atul Bioscience Ltd Received EIR from the US FDA for its Ambernath Facilit
Updated : 1 year, 7 months ago IST
Mumbai (Maharashtra) [India], August 12: Atul Bioscience Ltd (ABL), a 100 per cent subsidiary company of Atul Ltd, received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its manufacturing facility situated in Ambernath, Maharashtra.
Read More
India extends humanitarian assistance to Cuba, including 90 tonnes of nine
Updated : 1 year, 9 months ago IST
India has extended humanitarian assistance to Cuba, which includes a consignment of approx 90 tonnes of nine Made in India Active Pharmaceutical Ingredients ( APIs), the Ministry of External Affairs said in a release on Sunday.
Read More
Medec Medicare Limited Bags Prestigious India's Best Managed & Promisi
Updated : 1 year, 10 months ago IST
Mumbai (Maharashtra) [India], May 23: Medec Medicare Limited, India's fastest growing global pharmaceutical company specializing in intermediates & advanced intermediates of Active Pharmaceutical Ingredients (APIs) received a significant milestone by receiving the prestigious & covet
Read More
Morepen Laboratories Limited' Q3 FY24 EBITDA Surges by 151%, Net Profit Re
Updated : 2 years, 1 month ago IST
Mumbai (Maharashtra) [India], February 3: Morepen Laboratories Limited (NSE: MOREPENLAB, BSE: 500288), is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical Ingredients (APIs), branded and generic formulations and also the Home
Read More
Infinium Pharmachem Limited announces its IPO for March 31, 2023, To be li
Updated : 2 years, 12 months ago IST
New Delhi [India], March 27 (ANI/PNN): Infinium Pharmachem Limited, engaged in the manufacturing and supplying of Iodine Derivatives, Pharma Intermediates and Active Pharmaceutical Ingredients (APIs), brings its IPO for Rs. 2525.72 Lakhs on the March 31, 2023.
Read More
Pharma MNCs finding it difficult to survive in Pakistan
Updated : 3 years, 8 months ago IST
Islamabad [Pakistan], July 25 (ANI): Several foreign pharmaceutical multinational corporations (MNCs) are planning to move out of Pakistan after the government imposed heavy taxes on active pharmaceutical ingredients (APIs) and other raw materials which has led to a spike in production costs
Read More
Rising input costs to hurt profitability of Indian pharma sector in 2022-2
Updated : 3 years, 8 months ago IST
New Delhi [India], July 19 (ANI): Faced with rising prices of active pharmaceutical ingredients (APIs), and other key inputs coupled with a rise in freight and energy costs, the operating profitability of Indian pharmaceutical companies is expected to decline by 200-250 basis points (or 2.5
Read More